Enter your login e-mail to the account
Search
Search parameters
Search results
- New indication of metabolic and bariatric surgery
doc. MUDr. Pavol Holéczy, CSc.
(5/2024, Topic of the year ) - Victoza (liraglutid)
MUDr. Jitka Jurková
(4/2011, Drugs & drug classes ) - Antiatherogenic effect and cardiovascular benefit of GLP-1 receptor´s agonists
doc. MUDr. Štefan Farský, CSc., FESC
(4/2022, Drugs & drug classes ) - Obesity and cardiovascular system
doc. MUDr. Štefan Farský, CSc., FESC
(5/2010, Review articles ) - Future of hypolipidemic therapy
MUDr. Fábryová Ľubomíra, PhD.
(5/2010, Topic of the year ) - Physical activity recommendations in the management of patients with obesity and type 2. diabetes
Doc. MUDr. Barbara Ukropcová, PhD., prof. MUDr. Dušan Hamar, PhD., Mgr. Jozef Ukropec, DrSc.
(1/2020, Review articles ) - Anticoagulant therapy in patients with atrial fibrillation
Doc. MUDr. Ján Kmec, PhD., MPH
(2/2017, Review articles ) - Physical exercise – mandatory part of complex dyslipidemia managment
prof. MUDr. Dušan Meško, PhD.
(7-8/2009, Topic of the year ) - Dietary principles of treatment of obesity
MUDr. Viera Kissová, PhD.
(3/2015, Topic of the year ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - Bariatric/metabolic surgery of diabesity
doc. MUDr. Pavol Holéczy, CSc.
(6/2020, Topic of the year ) - NON-PHARMACOLOGICAL AND PHARMACOLOGICAL POSSIBILITIES IN THERAPY OF OBESE PATIENTS WITH METABOLIC SYNDROME
doc. MUDr. Boris Krahulec, CSc.
(S4/2007, Supplement ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - Pharmacokinetic changes in obese patients General overview and presentation of the working group of the Czech Professional Society of Clinical Pharmacy
PharmDr. Alena Pilková, PharmDr. Jan Miroslav Hartinger, Ph.D.
(1/2024, Topic of the year ) - Psychology in the management of obesity
Mgr. Margita Fülleová
(3/2016, Topic of the year ) - Appraisal of the health ability for driving the motor vehicle with the relationship of the obstructive sleep apnea syndrome
MUDr. Imrich Mucska
(3/2016, Review articles ) - THERAPY OF OBESE PATIENTS WITH DIABETES MELLITUS
doc. MUDr. Boris Krahulec, CSc., MUDr. Daša Habdáková
(12/2005, Topic ) - PHARMACOTHERAPY OF OBESITY
prof. MUDr. Juraj Payer, CSc., MUDr. Adriana Petrusová
(12/2005, Topic ) - Cardiovascular risk in diabetics
prof. MUDr. Miroslav Souček, CSc., MUDr. Petr Žák
(6/2015, Review articles ) - INSULIN RESISTANCE AND THE POLYCYSTIC OVARY SYNDROME
prof. MUDr. Ivica Lazúrová, CSc., MUDr. Ingrid Dravecká
(5/2005, Topic ) - Combined hypolipidemic therapy using statins and fibrates reducing the cardiovascular risk in the patients with atherogenic dyslipidemia
prof. MUDr. Vladimír Bláha, CSc.
(4/2010, Topic of the year ) - INCRETIN-BASED THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(7-8/2008, Topic ) - WEIGHT MANAGEMENT FOR OBESE TYPE 2 DIABETICS
MUDr. Ľubomíra Fábryová, PhD.
(7-8/2008, Topic ) - Clinical and legislative aspects of dietary supplements in weight reduction
Doc. PharmDr. Daniela Mináriková, PhD., MSc., MPH, doc. MUDr. Peter Minárik, PhD., MSc., MPH, doc. MUDr. Ľubomíra Fábryová, PhD., MPH
(3/2025, Topic of the year ) - OBESITY AND TYPE 2 DIABETES (DIABESITY) – TWO CLOSELY RELATED, PREVENTABLE DISEASES IS THE THERAPY OF OBESITY TOOL FOR PREVENTION OF METABOLIC SYNDROME AND TYPE 2 DIABETES?
MUDr. Ľubomíra Fábryová
(12/2006, Topic ) - Športovanie ako účinný preventívny prvok pred vznikom civilizačných ochorení .
prof. MUDr. Dušan Meško, PhD.
(12/2006, Memorix ) - Prediabetes
Doc. MUDr. Katarína Gazdíková, PhD., MHA, MPH, mim. prof.
(1/2017, Review articles ) - RELATIONSHIP OF VISCERAL OBESITY TO CARDIOMETABOLIC RISK FACTORS
MUDr. Ľubomíra Fábryová, PhD.
(3/2008, Topic )
- Would therapeutic drug monitoring improve adherence and efficaccy of treatment in schizophrenia?
prof. MUDr. Eva Češková, CSc.
(4/2011, Original articles & case reports ) - Practical aspects and several new horizons for the use of ziprasidone
MUDr. Michal Patarák
(3/2013, Psychopharmacology ) - Food Intake Disturbances in Teenage Girls with Type 1 Diabetes Mellitus
PhDr. Tamara Hrachovinová
(1/2002, Review articles )
- Intracerebral hemorrhage and anticoagulation therapy
prof. MUDr. Roman Herzig, Ph.D., FESO
(2/2014, Review articles )
- Použitie rastových faktorov myelopoézy v profylaxii febrilnej neutropénie
MUDr. Juraj Chudej, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Ivana Plameňová, PhD., MUDr. Ľubica Váleková, PhD., Prof. MUDr. Ján Staško, PhD.
(2/2018, Review articles ) - Some Aspects of Venous Thromboembolism in Patients with Solid Tumours
MUDr. Katarína Dostálová, MUDr. Patrik Palacka, PhD.
(6/2010, Review articles )
- Current perspective on treating lymphoedema
MUDr. Naděžda Vojáčková
(3/2022, Review articles )
- Safe and effective antihypertensive therapy in obesity
PharmDr. Iva Prokopová, Ph.D.
(4/2016, Clinical pharmacy ) - Pharmacokinetic changes in obese patients General overview and presentation of the working group of the Czech Professional Society of Clinical Pharmacy
PharmDr. Alena Pilková, PharmDr. Jan Miroslav Hartinger, Ph.D.
(4/2024, Current pharmacotherapy ) - Victoza (liraglutid)
MUDr. Jitka Jurková
(3/2011, New medicinal substances )
- Intracerebral hemorrhage and anticoagulation therapy
prof. MUDr. Roman Herzig, Ph.D., FESO
(2/2014, Main topic ) - Some Aspects of Venous Thromboembolism in Patients with Solid Tumours
MUDr. Katarína Dostálová, MUDr. Patrik Palacka, PhD.
(3/2011, Review articles )